From Trial-and-Error to Targeted Success: How Computational Disease Models Can Help Patients and Pharma Companies
The in-depth, constantly-changing birds-eye view of disease that computational models provide is an essential next…
The in-depth, constantly-changing birds-eye view of disease that computational models provide is an essential next step in linking our ever-expanding clinical knowledge and data with drug development. The post From Trial-and-Error to Targeted Success: How Computational Disease Models Can Help Patients and Pharma Companies appeared first on MedCity News.
Here’s how alternative care pathways are changing the way we think about patient discharge and how to create effective and safe disposition options from both emergency department (ED) and inpatient settings. The post Care Without Walls: Scaling Alternatives to Skilled Nursing Facilities appeared first on MedCity News.
[Sponsored] A July 22 webinar, scheduled for 1 pm ET and sponsored by Verato, will explore why the next era of payer performance will depend on building a trusted data foundation that connects people, providers, and relationships across the enterprise. The post The Payer AI Readiness Gap: Why Better Data Will Define the Next Era…
One afternoon in late 2024, a sixth-grader nicknamed Bug came home from school with an announcement to make. Bug, who was assigned female at birth, told his parents he was a boy — and would be using he/him pronouns. “OK, cool,” his mother, J, remembered saying. (J asked to be identified by only her first…
Angel Foster had a backup plan. It was the first weekend in May. A federal appeals court had just made it illegal to mail mifepristone, a pill that’s part of the most widely used abortion method in the U.S. But Foster, a doctor who specializes in reproductive health, was prepared. As leader of the Massachusetts…
The biotech IPOs window is now open, but that doesn’t mean every company can go through it. A panel at the BIO Convention in San Diego discussed the steps biotech companies should take if they’re considering a public listing. The post The Things to Think About Before Taking Your Biotech Company Public appeared first on…
Cadence raised $100 million in Series C funding to scale its AI-powered chronic care platform, which monitors patients at home and adjusts their medications in real time.The startup, now valued at $1.23 billion, partners with health systems to treat patients with heart failure, hypertension and diabetes. The post Cadence Rakes In $100M to Automate Chronic…
Ladder Health’s seed round was led by Nina Capital, with participation from Mairs & Power Venture Capital, South Dakota First Capital, 25madison Health, Hatteras Venture Partners, Create Health Ventures, Jumpstart Capital, White Oak Enterprises, Groove Capital and 7Rock Ventures. The post Startup Raises $7M for Virtual-First Pediatric Therapy Model appeared first on MedCity News.
This tracker provides a listing of global health-related legislation introduced in the current Congress.
This brief describes new guidance and potential challenges states will face in operationalizing the medical frailty exemption.